154 related articles for article (PubMed ID: 38330916)
21. Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.
Li Y; Kobayashi H; Hashimoto Y; Shirai R; Hirata A; Hayashi K; Hamada Y; Shioiri T; Iwasaki S
Chem Biol Interact; 1994 Dec; 93(3):175-83. PubMed ID: 7923438
[TBL] [Abstract][Full Text] [Related]
22. Targeted natural products discovery from marine cyanobacteria using combined phylogenetic and mass spectrometric evaluation.
Salvador-Reyes LA; Engene N; Paul VJ; Luesch H
J Nat Prod; 2015 Mar; 78(3):486-92. PubMed ID: 25635943
[TBL] [Abstract][Full Text] [Related]
23. Pitiprolamide, a proline-rich dolastatin 16 analogue from the marine cyanobacterium Lyngbya majuscula from Guam.
Montaser R; Abboud KA; Paul VJ; Luesch H
J Nat Prod; 2011 Jan; 74(1):109-12. PubMed ID: 21138309
[TBL] [Abstract][Full Text] [Related]
24. Antineoplastic agents. 599. Total synthesis of dolastatin 16.
Pettit GR; Smith TH; Arce PM; Flahive EJ; Anderson CR; Chapuis JC; Xu JP; Groy TL; Belcher PE; Macdonald CB
J Nat Prod; 2015 Mar; 78(3):476-85. PubMed ID: 25689568
[TBL] [Abstract][Full Text] [Related]
25. Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis.
Gunasekera SP; Miller MW; Kwan JC; Luesch H; Paul VJ
J Nat Prod; 2010 Mar; 73(3):459-62. PubMed ID: 20020755
[TBL] [Abstract][Full Text] [Related]
26. Marine Antitumor Peptide Dolastatin 10: Biological Activity, Structural Modification and Synthetic Chemistry.
Gao G; Wang Y; Hua H; Li D; Tang C
Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34202685
[TBL] [Abstract][Full Text] [Related]
27. Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.
Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Paul VJ
J Nat Prod; 1999 Apr; 62(4):655-8. PubMed ID: 10217737
[TBL] [Abstract][Full Text] [Related]
28. Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agents.
Zask A; Kaplan J; Musto S; Loganzo F
J Am Chem Soc; 2005 Dec; 127(50):17667-71. PubMed ID: 16351096
[TBL] [Abstract][Full Text] [Related]
29. Antineoplastic agents 365. Dolastatin 10 SAR probes.
Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
[TBL] [Abstract][Full Text] [Related]
30. Antineoplastic agents. 592. Highly effective cancer cell growth inhibitory structural modifications of dolastatin 10.
Pettit GR; Hogan F; Toms S
J Nat Prod; 2011 May; 74(5):962-8. PubMed ID: 21534541
[TBL] [Abstract][Full Text] [Related]
31. Veraguamides A-G, cyclic hexadepsipeptides from a dolastatin 16-producing cyanobacterium Symploca cf. hydnoides from Guam.
Salvador LA; Biggs JS; Paul VJ; Luesch H
J Nat Prod; 2011 May; 74(5):917-27. PubMed ID: 21446699
[TBL] [Abstract][Full Text] [Related]
32. The wewakpeptins, cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena.
Han B; Goeger D; Maier CS; Gerwick WH
J Org Chem; 2005 Apr; 70(8):3133-9. PubMed ID: 15822975
[TBL] [Abstract][Full Text] [Related]
33. Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin.
Cruz-Monserrate Z; Vervoort HC; Bai R; Newman DJ; Howell SB; Los G; Mullaney JT; Williams MD; Pettit GR; Fenical W; Hamel E
Mol Pharmacol; 2003 Jun; 63(6):1273-80. PubMed ID: 12761336
[TBL] [Abstract][Full Text] [Related]
34. Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc.
Turner T; Jackson WH; Pettit GR; Wells A; Kraft AS
Prostate; 1998 Feb; 34(3):175-81. PubMed ID: 9492845
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological activity of chimeric structures derived from the cytotoxic natural compounds dolastatin 10 and dolastatin 15.
Poncet J; Busquet M; Roux F; Pierré A; Atassi G; Jouin P
J Med Chem; 1998 Apr; 41(9):1524-30. PubMed ID: 9554885
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10.
Poncet J; Hortala L; Busquet M; Guéritte-Voegelein F; Thoret S; Pierré A; Atassi G; Jouin P
Bioorg Med Chem Lett; 1998 Oct; 8(20):2855-8. PubMed ID: 9873636
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antitumor activity of novel dolastatin 10 analogs.
Miyazaki K; Kobayashi M; Natsume T; Gondo M; Mikami T; Sakakibara K; Tsukagoshi S
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1706-18. PubMed ID: 8536345
[TBL] [Abstract][Full Text] [Related]
38. Discovery of cytotoxic dolastatin 10 analogues with N-terminal modifications.
Maderna A; Doroski M; Subramanyam C; Porte A; Leverett CA; Vetelino BC; Chen Z; Risley H; Parris K; Pandit J; Varghese AH; Shanker S; Song C; Sukuru SC; Farley KA; Wagenaar MM; Shapiro MJ; Musto S; Lam MH; Loganzo F; O'Donnell CJ
J Med Chem; 2014 Dec; 57(24):10527-43. PubMed ID: 25431858
[TBL] [Abstract][Full Text] [Related]
39. Total synthesis of odoamide, a novel cyclic depsipeptide, from an Okinawan marine cyanobacterium.
Kaneda M; Sueyoshi K; Teruya T; Ohno H; Fujii N; Oishi S
Org Biomol Chem; 2016 Sep; 14(38):9093-9104. PubMed ID: 27722687
[TBL] [Abstract][Full Text] [Related]
40. Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography.
Cruz-Monserrate Z; Mullaney JT; Harran PG; Pettit GR; Hamel E
Eur J Biochem; 2003 Sep; 270(18):3822-8. PubMed ID: 12950266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
